The global Non-Invasive Blood Glucose Monitoring System market size in 2023 is 26.9 million US dollars, and it is expected to be 110.8 million US dollars by 2030, with a compound annual growth rate of 22.4% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Non-Invasive Blood Glucose Monitoring System market include Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd., Ascensia Diabetes Care, and Dexcom, Inc.. The share of the top 3 players in the Non-Invasive Blood Glucose Monitoring System market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Non-Invasive Blood Glucose Monitoring System market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Spectroscopy accounted for XX% of Non-Invasive Blood Glucose Monitoring System market in 2023. Electromagnetic share of XX%.
Hospitals accounted for XX% of the Non-Invasive Blood Glucose Monitoring System market in 2023. Homecare accounts for XX%.
This Non-Invasive Blood Glucose Monitoring System market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.
Non-Invasive Blood Glucose Monitoring System market country level analysis
The countries covered in the Non-Invasive Blood Glucose Monitoring System market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.
Competitive Landscape and Non-Invasive Blood Glucose Monitoring System Market Share Analysis
Non-Invasive Blood Glucose Monitoring System market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Non-Invasive Blood Glucose Monitoring System market.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the Non-Invasive Blood Glucose Monitoring System industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of Non-Invasive Blood Glucose Monitoring System market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapters 4-6: Segmented the global Non-Invasive Blood Glucose Monitoring System market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Non-Invasive Blood Glucose Monitoring System market type, application, country and player market segmentation data, and include SWOT Analysis.
Chapter 12: Analyzes the Non-Invasive Blood Glucose Monitoring System business cost, including industrial chain and the proportion of business cost structure.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa
Player list
Abbott Laboratories
Medtronic plc
F. Hoffmann-La Roche Ltd.
Ascensia Diabetes Care
Dexcom, Inc.
Sanofi Novo Nordisk
Insulet Corporation
Ypsomed Holdings
Glysens Incorporated
Types list
Spectroscopy
Electromagnetic
Microwave
Ultrasonic
Thermal
Others
Application list
Hospitals
Homecare
Clinics
Table of Content
1 Market Overview
1.1 Non-Invasive Blood Glucose Monitoring System Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Non-Invasive Blood Glucose Monitoring System Market Size & Forecast
1.4.1 Global Non-Invasive Blood Glucose Monitoring System Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Non-Invasive Blood Glucose Monitoring System Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Non-Invasive Blood Glucose Monitoring System Market Drivers
1.5.2 Non-Invasive Blood Glucose Monitoring System Market Restraints
1.5.3 Non-Invasive Blood Glucose Monitoring System Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Abbott Laboratories SWOT Analysis
2.1.3 Abbott Laboratories Non-Invasive Blood Glucose Monitoring System Products and Service Offered
2.1.4 Abbott Laboratories Non-Invasive Blood Glucose Monitoring System Revenue and Gross Margin
2.2 Medtronic plc
2.2.1 Business Overview
2.2.2 Medtronic plc SWOT Analysis
2.2.3 Medtronic plc Non-Invasive Blood Glucose Monitoring System Products and Service Offered
2.2.4 Medtronic plc Non-Invasive Blood Glucose Monitoring System Revenue and Gross Margin
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 Business Overview
2.3.2 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.3.3 F. Hoffmann-La Roche Ltd. Non-Invasive Blood Glucose Monitoring System Products and Service Offered
2.3.4 F. Hoffmann-La Roche Ltd. Non-Invasive Blood Glucose Monitoring System Revenue and Gross Margin
2.4 Ascensia Diabetes Care
2.4.1 Business Overview
2.4.2 Ascensia Diabetes Care SWOT Analysis
2.4.3 Ascensia Diabetes Care Non-Invasive Blood Glucose Monitoring System Products and Service Offered
2.4.4 Ascensia Diabetes Care Non-Invasive Blood Glucose Monitoring System Revenue and Gross Margin
2.5 Dexcom, Inc.
2.5.1 Business Overview
2.5.2 Dexcom, Inc. SWOT Analysis
2.5.3 Dexcom, Inc. Non-Invasive Blood Glucose Monitoring System Products and Service Offered
2.5.4 Dexcom, Inc. Non-Invasive Blood Glucose Monitoring System Revenue and Gross Margin
2.6 Sanofi Novo Nordisk
2.6.1 Business Overview
2.6.2 Sanofi Novo Nordisk SWOT Analysis
2.6.3 Sanofi Novo Nordisk Non-Invasive Blood Glucose Monitoring System Products and Service Offered
2.6.4 Sanofi Novo Nordisk Non-Invasive Blood Glucose Monitoring System Revenue and Gross Margin
2.7 Insulet Corporation
2.7.1 Business Overview
2.7.2 Insulet Corporation SWOT Analysis
2.7.3 Insulet Corporation Non-Invasive Blood Glucose Monitoring System Products and Service Offered
2.7.4 Insulet Corporation Non-Invasive Blood Glucose Monitoring System Revenue and Gross Margin
2.8 Ypsomed Holdings
2.8.1 Business Overview
2.8.2 Ypsomed Holdings SWOT Analysis
2.8.3 Ypsomed Holdings Non-Invasive Blood Glucose Monitoring System Products and Service Offered
2.8.4 Ypsomed Holdings Non-Invasive Blood Glucose Monitoring System Revenue and Gross Margin
2.9 Glysens Incorporated
2.9.1 Business Overview
2.9.2 Glysens Incorporated SWOT Analysis
2.9.3 Glysens Incorporated Non-Invasive Blood Glucose Monitoring System Products and Service Offered
2.9.4 Glysens Incorporated Non-Invasive Blood Glucose Monitoring System Revenue and Gross Margin
3 Global Non-Invasive Blood Glucose Monitoring System Market Competition, by Manufacturer
3.1 Global Non-Invasive Blood Glucose Monitoring System Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Non-Invasive Blood Glucose Monitoring System Players Market Share in 2023
3.2.2 Top 6 Non-Invasive Blood Glucose Monitoring System Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Non-Invasive Blood Glucose Monitoring System Players Head Office, Business Provided
3.4 Non-Invasive Blood Glucose Monitoring System Mergers & Acquisitions
3.5 Non-Invasive Blood Glucose Monitoring System New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Non-Invasive Blood Glucose Monitoring System Revenue in Value by Type (2019-2030)
4.2 Global Non-Invasive Blood Glucose Monitoring System Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Non-Invasive Blood Glucose Monitoring System Revenue by Application (2019-2030)
5.2 Global Non-Invasive Blood Glucose Monitoring System Revenue Share by Application (2019-2030)
6 Global Non-Invasive Blood Glucose Monitoring System Market Analysis by Regions
6.1 Global Non-Invasive Blood Glucose Monitoring System Revenue and Market Share by Regions
6.1.1 Global Non-Invasive Blood Glucose Monitoring System Revenue by Regions (2019-2030)
6.1.2 Global Non-Invasive Blood Glucose Monitoring System Revenue Market Share by Regions (2019-2030)
6.2 North America Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
6.3 Europe Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
6.4 Asia Pacific Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
6.5 South America Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
6.6 Middle East and Africa Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
7 North America Non-Invasive Blood Glucose Monitoring System by Country, by Type, and by Application
7.1 North America Non-Invasive Blood Glucose Monitoring System Revenue by Type (2019-2030)
7.2 North America Non-Invasive Blood Glucose Monitoring System Revenue by Application (2019-2030)
7.3 North America Non-Invasive Blood Glucose Monitoring System Revenue and Market Share by Countries
7.3.1 North America Non-Invasive Blood Glucose Monitoring System Revenue in Value by Country (2019-2030)
7.3.2 United States Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
7.3.3 Canada Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
7.3.4 Mexico Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Non-Invasive Blood Glucose Monitoring System by Country, by Type, and by Application
8.1 Europe Non-Invasive Blood Glucose Monitoring System Revenue by Type (2019-2030)
8.2 Europe Non-Invasive Blood Glucose Monitoring System Revenue by Application (2019-2030)
8.3 Europe Non-Invasive Blood Glucose Monitoring System Revenue and Market Share by Countries
8.3.1 Europe Non-Invasive Blood Glucose Monitoring System Revenue in Value by Country (2019-2030)
8.3.2 Germany Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
8.3.3 France Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
8.3.4 United Kingdom Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
8.3.5 Russia Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
8.3.6 Italy Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
8.3.7 Nordic Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Non-Invasive Blood Glucose Monitoring System by Country, by Type, and by Application
9.1 Asia Pacific Non-Invasive Blood Glucose Monitoring System Revenue by Type (2019-2030)
9.2 Asia Pacific Non-Invasive Blood Glucose Monitoring System Revenue by Application (2019-2030)
9.3 Asia Pacific Non-Invasive Blood Glucose Monitoring System Revenue and Market Share by Countries
9.3.1 Asia Pacific Non-Invasive Blood Glucose Monitoring System Revenue in Value by Country (2019-2030)
9.3.2 China Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
9.3.3 Japan Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
9.3.4 Korea Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
9.3.5 India Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
9.3.7 Australia Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Non-Invasive Blood Glucose Monitoring System by Country, by Type, and by Application
10.1 South America Non-Invasive Blood Glucose Monitoring System Revenue by Type (2019-2030)
10.2 South America Non-Invasive Blood Glucose Monitoring System Revenue by Application (2019-2030)
10.3 South America Non-Invasive Blood Glucose Monitoring System Revenue and Market Share by Countries
10.3.1 South America Non-Invasive Blood Glucose Monitoring System Revenue in Value by Country (2019-2030)
10.3.2 Brazil Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
10.3.3 Argentina Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Non-Invasive Blood Glucose Monitoring System by Country, by Type, and by Application
11.1 Middle East & Africa Non-Invasive Blood Glucose Monitoring System Revenue by Type (2019-2030)
11.2 Middle East & Africa Non-Invasive Blood Glucose Monitoring System Revenue by Application (2019-2030)
11.3 Middle East & Africa Non-Invasive Blood Glucose Monitoring System Revenue and Market Share by Countries
11.3.1 Middle East & Africa Non-Invasive Blood Glucose Monitoring System Revenue in Value by Country (2019-2030)
11.3.2 Turkey Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
11.3.3 Egypt Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
11.3.5 UAE Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
11.3.6 South Africa Non-Invasive Blood Glucose Monitoring System Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Non-Invasive Blood Glucose Monitoring System Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Non-Invasive Blood Glucose Monitoring System Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer